利加生醫股份有限公司
- 英文名稱:EliteCell BioMedical Corp.
- 網址:http://www.elitecellbio.com/
- 成立時間:2017-10-03
- 發展階段:尚未IPO
- 地區:臺北市南港區園區街3號17樓
- 資本額:3,078,480
- 代表人:黃耀飛
產業領域
A05生物製劑(生物藥、抗體、蛋白質、疫苗)、C06再生醫療(細胞治療、基因治療、組織工程等)
簡介
With more than 10 years of extensive GMP manufacturing experience in the cell supplement market, Biomedical EliteCell Corp. focuses on developing advanced solutions for research and commercial development of cell therapies. In collaboration with FDA-licensed and AABB-accredited blood centers in the USA for raw materials, Biomedical EliteCell Corp. offers products that are 100% traceable . Our GMP-compliant facility located in Texas contains an integrated quality management system and follows FDA regulation 21CFR Part 820.